2027 Summer Intern Finance (IOPS)
Regeneron Pharmaceuticals
Summary
Regeneron is currently seeking 2027 Interns in Finance teams of Regeneron Industrial Operations and Product Supply (IOPS). These teams support the financial operations of a global biotechnology company.
Job description
When & where
Location: Rensselaer. Timeframe: Our internship positions are full-time and onsite from May/June-August. Pay: Intern and Co-op pay ranges are determined by level of education (year in school) and degree program. The hourly rate range for these locations is: $17.90-$25.50 per hour.
What you'll do
- Gain hands-on experience in the financial operations of a global biotechnology company as IOPS Finance evolves to support a growing IOPS organization.
- Projects may include supporting financial planning, forecasting, and variance analysis, analyzing costs, preparing financial reports, and supporting finance systems and process improvements.
- One potential project: build dashboards that bring budget, forecast, actuals, spend, and inventory data into one clear, unified view for business leaders in functions such as External Manufacturing and Supply Chain.
- You would lead a defined project with clear goals set at the start of the summer, with the freedom to choose your approach and shape the design. Your finance manager will provide guidance and regular check-ins, and the tools you build may expand to other IOPS functions, creating lasting impact beyond the summer.
- Expect substantial work in Excel, close attention to detail, and the chance to summarize your analysis for the finance team.
- Accounting or finance coursework and intermediate Excel skills are helpful; experience visualizing data and familiarity with AI tools are a plus.
Relevant majors
Finance, Accounting, Economics, Business, Statistics/Data Science
Let's find out if we're a fit
- Demonstrated leadership in areas such as campus activities, clubs, sports, current or previous work, or within the community preferred
- Must be enrolled in, or accepted to, an academic program pursuing an Undergraduate or Graduate degree (and be returning to school the semester following the position or graduating after the position)
- Cumulative GPA of 3.0 or higher preferred
Requirements
- Must be enrolled in, or accepted to, an academic program pursuing an Undergraduate or Graduate degree
- Must be returning to school the semester following the position or graduating after the position
- Relevant majors: Finance, Accounting, Economics, Business, Statistics/Data Science
- Accounting or finance coursework helpful
- Intermediate Excel skills helpful
- Experience visualizing data a plus
- Familiarity with AI tools a plus
- Demonstrated leadership preferred
- Cumulative GPA of 3.0 or higher preferred
Benefits
- Annual Bonuses
- Equity Awards
- Pension or Retirement Benefits
- 401(k) Matching
- Health and Wellness Programs
- Fitness Centers
- Medical, Dental & Vision
- Paid Time Off
- Family Support Benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.